Astrazeneca

FromAstraZeneca ([email protected])
Subject (109)AstraZeneca enters license agreement with Alteogen for subcutaneous formulations of multiple oncology assets
Preheader (47)͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Typography
Arial
Colors
Text Analysis
Body Words233
Subject Words13
Body Emojis2
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px752 px
X-Spam Score0.7
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeEarly Morning

AstraZeneca enters license agreement with Alteogen for subcutaneous formulations of multiple oncology assets

͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
AstraZeneca enters license agreement with Alteogen for subcutaneous formulations of multiple oncology assets